RARE
Ultragenyx Pharmaceutical Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$21.34
-0.37 ▼ -1.70%
🌙 3월 13일 7:55 PM ET (한국 3/14 08:55)
$21.76
+0.42 ▲ +1.97%
| Index | - | P/E | - | EPS (ttm) | -5.84 | Insider Own | 5.53% | Shs Outstand | 0.10B | Perf Week | 0.42% |
| Market Cap | 2.06B | Forward P/E | - | EPS next Y | 88.52% | Insider Trans | -2.35% | Shs Float | 0.09B | Perf Month | -10.64% |
| Enterprise Value | 2.63B | PEG | - | EPS next Q | -1.43 | Inst Own | 97.8% | Short Float | 10.51% | Perf Quarter | -40.72% |
| Income | -0.58B | P/S | 3.07 | EPS this Y | 25.2% | Inst Trans | -2.94% | Short Ratio | 3.41 | Perf Half Y | -31.67% |
| Sales | 0.67B | P/B | - | EPS next 5Y | - | ROA | -37.91% | Short Interest | 9.60M | Perf YTD | -7.22% |
| Book/sh | -0.83 | P/C | 2.98 | EPS past 3/5Y | 16.78% -13.72% | ROE | -656.54% | 52W High | -49.63% ($42.37) | Perf Year | -45.63% |
| Cash/sh | 7.17 | P/FCF | - | Sales past 3/5Y | 22.81% 19.95% | ROIC | -52.74% | 52W Low | 15.92% ($18.41) | Perf 3Y | -47.8% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 7.91% | Gross Margin | 78.65% | Volatility(W/M) | 5.11% 5.45% | Perf 5Y | -83.19% |
| Dividend TTM | - | EV/Sales | 3.91 | Sales Y/Y TTM | 20.08% | Oper. Margin | -79.63% | ATR (14) | 1.13 | Perf 10Y | -64.43% |
| Dividend Ex-Date | - | Quick Ratio | 2.34 | EPS Q/Q | 7.37% | Profit Margin | -85.54% | RSI (14) | 40.55 | Recom | 1.19 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.48 | Sales Q/Q | 25.55% | SMA20 | -3.13% ($22.03) | Beta | 0.22 | Target Price | $54.25 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | -7.56% ($23.09) | Rel Volume | 0.9 | Prev Close | $21.71 |
| Employees | 1371 | LT Debt/Eq | - | EPS/Sales Surpr. | -18.07% 4.23% | SMA200 | -28.87% ($30) | Avg Volume(3M) | 2.82M | Price | $21.34 |
| IPO | 2014/1/31 | Option/Short | Yes/Yes | Trades | 13201 | Volume | 2,543,334 | Change | -1.7% |
뉴스 로딩 중...